As 2024 comes to a close, Biolytic Lab Performance celebrates a year dedicated to empowering our customers’ success in oligonucleotide synthesis. From delivering new oligo synthesis product and tool offerings to strengthening partnerships, every accomplishment this year has been driven by our commitment to meeting the evolving needs of our customers.
Join us in reflecting on the milestones that have solidified Biolytic as a trusted partner in oligonucleotide synthesis, helping researchers and organizations achieve breakthroughs in research and discovery.
New Resources and Tools for Oligo Success
A key highlight of 2024 was the launch of new resources and tools designed to support our customers’ success in oligo synthesis. These include a Publications Page showcasing scientific journal references featuring our Dr. Oligo DNA/RNA Synthesizers, a Reagent Consumption Calculator for estimating synthesis costs, and a dedicated blog to keep customers informed on the latest industry trends and Biolytic news. These initiatives reflect our dedication to equipping customers with the tools and knowledge they need to achieve their goals in oligo synthesis.
- Resources | Biolytic Lab Performance, Inc
- Publications | Biolytic Lab Performance, Inc
- reagent-calculator-48192
- reagent-calculator-768
New Oligo Synthesis Product Offerings
Another major highlight of 2024 was the introduction of new product offerings tailored to enhance customer success in oligo synthesis. We introduced custom column solutions to better support your unique oligo synthesis needs, allowing collaboration to develop tailored solutions. Additionally, we launched a Synthesis Protocol Development Service, partnering with customers to create custom working protocols optimized for their unique columns and Dr. Oligo synthesizers. These offerings reflect our commitment to fostering collaboration and delivering personalized solutions that empower researchers to achieve their synthesis goals with precision and efficiency.
Our Software Team has been hard at work developing exciting new features to enhance the oligo synthesis experience. The Dr. Oligo Synthesizer already leverages advanced, modern software designed to deliver the features needed for today’s cutting-edge research and beyond. Stay tuned as we continue to innovate and provide solutions that empower researchers to achieve their goals with ease and efficiency.
Excellence in Manufacturing and Quality Control
In 2024, our Manufacturing, Materials, and Quality Control Teams continued to set the standard for excellence, producing our industry-leading Dr. Oligo DNA/RNA Synthesizers at our headquarters in Fremont, California. With a focus on on-time deliveries, enhanced safety measures, and unwavering dedication to precision, these teams have ensured that every instrument meets the highest standards of quality and reliability. This commitment translates into tangible benefits for our customers, including reduced downtime, consistent performance, and peace of mind knowing their tools are built to support their most critical research goals. Their dedication to manufacturing excellence reinforces our mission to provide dependable, U.S.-crafted solutions for researchers worldwide.
Enhancing Customer Support with a New Technical Support Structure
In 2024, we launched a new technical support structure to better serve our customers’ needs in oligo synthesis. This enhanced approach includes expanded support hours, faster response times, and the introduction of a Priority Support Tier for customers requiring expedited assistance. Our support services are backed by a dedicated team of oligo experts, ready to assist with part numbers or replacements, synthesis troubleshooting, and addressing instrument hardware or software questions. By combining expert guidance with tailored solutions, we’re ensuring our customers have the resources they need to overcome challenges and achieve success at every stage of their research.
Strengthening Compliance and Internal Processes through ISO Updates
In 2024, Biolytic Lab Performance made significant strides in regulating internal processes to align with the latest ISO standards, directly benefiting our customers. We’ve redefined our resolution criteria to better meet customer expectations, ensuring faster and more effective problem-solving. Key improvements have been made in handling customer requests, as well as enhancing cross-team functioning and communication to streamline workflows, resulting in quicker response times and more seamless support. Our efforts also include successfully passing audits from major customers, reinforcing our commitment to quality and compliance. Additionally, we’ve made advancements in supplier assessments and strengthened our calibration and maintenance programs, which enhance the reliability and performance of our products, providing customers with greater confidence in the consistency and quality of our solutions.
Joining the International Gene Synthesis Consortium (IGSC)
In 2024, Biolytic Lab Performance proudly joined the International Gene Synthesis Consortium (IGSC), further demonstrating our commitment to advancing safe and ethical practices in the gene synthesis industry. As an IGSC member, we support global initiatives aimed at ensuring responsible research and development in synthetic biology. This collaboration strengthens our ability to offer high-quality, compliant products that meet the evolving needs of our customers. By adhering to the IGSC’s standards and guidelines, we provide our partners with greater confidence in the integrity and safety of their oligo synthesis solutions.
Strengthening Partnerships and Support
In 2024, Biolytic Lab Performance focused on strengthening relationships with our customers through on-site visits, ensuring they know that when they choose Dr. Oligo Synthesizers, they’re not just purchasing an instrument – they’re joining a team of oligo experts dedicated to their success. During these visits, we provide personalized consultations, gather valuable feedback, and offer tailored solutions to help them succeed in their research and projects. By working closely with our customers, we ensure they receive the support they need and reinforce that they are an integral part of our team, collaborating to achieve breakthroughs and push the boundaries of oligo synthesis.
Conclusion
As we reflect on the highlights of 2024, Biolytic Lab Performance remains committed to empowering our customers and driving innovation in oligo synthesis. From launching new resources and tools to enhancing our technical support and joining the IGSC, each achievement reflects our dedication to providing end-to-end oligo synthesis solutions that meet the evolving needs of researchers. By strengthening relationships, offering tailored support, and ensuring the highest quality in every aspect of oligo synthesis, we strive to help our customers succeed in their research and discoveries, every step of the way. We look forward to continuing this journey together in 2025 and beyond. Thank you
